From 25-29 August 2018, leading experts from across the globe will convene in Munich for the world’s largest cardiovascular congress, the European Society of Cardiology (ESC) Congress 2018.
Cardiovascular disease is the term used for conditions that affect the heart and blood vessels and it is the number one cause of death worldwide. The population across the world is getting older and one of the results of this is the higher prevalence of cardiovascular diseases, among others. Despite the high prevalence of cardiovascular disease, there is still a high unmet medical need for many patients worldwide and the healthcare systems are struggling under mounting costs.
The ESC Congress explores how the treatment of cardiovascular diseases can be improved. We will also share our insights into how clinical development of innovative medicines and technologies at Bayer can help tackle the growing burden of cardiovascular diseases, including those patients with a high unmet medical need.
“There is still much that needs to be done to improve the lives of those living with cardiovascular diseases. At Bayer, we strive to explore how our therapies can benefit those patients who may currently have limited treatment options. We look forward to sharing the latest data from our clinical development program at ESC Congress 2018, and just as importantly, engaging in mutual learning with others in the field of cardiology.”
Dr Martin van Eickels, Senior Vice President, Medical Affairs, Bayer
Successful treatment starts with accurate diagnosis
Accurate and timely diagnosis of cardiovascular diseases is paramount to the way patients are subsequently treated. We are all aware of drugs that a patient can take in order to treat cardiovascular conditions, but how does a doctor choose the right treatment for the right patient?
Radiologists play an important role here, as their work maps out the next steps of the patient’s disease management journey:
- Diagnosis: Use of medical imaging such as ultrasound, MRI or CT helps cardiologists and radiologists to accurately diagnose diseases of the heart, such as coronary artery disease (CAD)
- Treatment: Timely and correct diagnosis informs doctor’s decisions so that they can select the right treatment for the right patient, thereby improving the quality of care
- Management: Radiologists can assist in monitoring how a disease is progressing, the patient’s response to treatment, as well as detection of other illnesses
Indeed, Dr Stephan Achenbach, Head of Cardiology at the University of Erlangen in Germany and the newly elected ESC President, cites collaboration between cardiology and radiology as one of his core philosophies for patient benefit6.
More than 110 million radiological examinations are performed annually worldwide with cardiac imaging representing a third of these7
"ESC Congress 2018 provides a great platform for the latest developments in the cardiac space at every step from diagnosis to care. Cardiac MR is important for the timely and correct diagnosis of a number of cardiovascular diseases such as Coronary Artery Disease to name just one. We are continuing to work with scientific partners to identify new insights and gather evidence that will strengthen diagnostic confidence and thereby leading to better outcomes for patients."
Dr. Thomas Balzer, Head Medical & Clinical Affairs Radiology at Bayer
Two types of cardiac imaging techniques:
A look into the future of cardiac imaging sees a continual focus on finding the best way to care for patients. The Society of Cardiovascular Magnetic Resonance (SCMR) has compiled a registry and database of over 65,000 CMR studies to promote the use of CMR in diagnosing and monitoring patients with cardiovascular disease. The name of the registry is SPINS and stands for “The Clinical Impact of Stress CMR Perfusion Imaging in the United States”. “Stress CMR Perfusion Imaging” is another term for CMR imaging.
Bayer is one of the collaborators on this initiative8 and the goal is to allow CMR professionals to share insights into how CMR impacts patient care and ultimately improve the way patients are treated. Dr. Raymond Kwong will share some important insights gained from the SPINS registry at the ESC Congress this year:
"In 2015, almost 9 million people worldwide died of Coronary Artery Disease, the most common type of heart disease. Gadolinium-enhanced stress cardiac MR perfusion imaging provides excellent diagnostic accuracy for coronary artery disease and negative clinical event rates. I am excited to present latest results from the SPINS - SCMR Registry at ESC Congress 2018 providing real-world evidence on stress cardiac MR across multiple centers in the US."
Dr. Raymond Y. Kwong, Director Cardiac Magnetic Resonance Imaging and Associate Professor, Harvard Medical School, Boston, United States of America
How can I follow Bayer at the ESC?